arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Bionano Genomics, Inc.

BNGO

$1.16 ▲ +0.06 (+5.94%) at close

10 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Bionano Genomics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.3M

Dividend Yield —

Revenue Growth -7.4% ↗

Op. Margin -116.9% ↗

ROIC -75.2% ↗

FCF / Share $-3.00 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$28.51M

↓ -7.4% —

Net Income Profit after all expenses

$-26.39M

↑ +76.4% —

Operating Margin Operating profit as % of sales

-116.9%

↑ +65.4% 2th

FCF / Share Free cash flow per share

$-3.00

↑ +94.5% —

Long-Term Debt Long-term obligations

$16.33M

↓ -18.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	-7.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-247%)	-14.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-396%)	29.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+498%)	54.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+992%)	111.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2129%)	-16.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-421%)	-15.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-412%)	26.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+425%)	—	—
EPS Growth YoY (%)	94.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	99.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-48.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-76.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	76.4% Excellent ↑ Excellent Improving Year-over-year change in net income	51.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-75.3% Weak ↓ Weak Declining Year-over-year change in net income	-83.1% Weak ↓ Weak Declining Year-over-year change in net income	-76.2% Weak ↓ Weak Declining Year-over-year change in net income	-37.9% Weak ↓ Weak Declining Year-over-year change in net income	-61.2% Weak Weak Year-over-year change in net income	20.8% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	94.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	0.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	19.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	61.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	40.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.4% Good Good Compound annual revenue growth over 3 years	-3.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	27.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	24.9% Excellent → Excellent Stable Compound annual revenue growth over 5 years	24.7% Excellent Excellent Compound annual revenue growth over 5 years	23.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-116.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1075%)	-337.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2916%)	—	-473.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4047%)	-428.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3673%)	-453.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3878%)	-255.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2229%)	-170.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1518%)	-244.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2136%)	—
Effective Tax Rate (%) (%)	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-92.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1257%)	-364.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4650%)	—	-476.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6062%)	-402.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-5136%)	-483.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6143%)	-294.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3779%)	-154.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2027%)	-245.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3173%)	—
FCF Margin (%) (%)	-57.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-223.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-346.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-448.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-400.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-450.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-292.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-169.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-229.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-75.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-294.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-223.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-75.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-109.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-106.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	46.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-45.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-135.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-100.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-63.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-85.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-82.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-228.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-59.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-496%)	—	-241.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1712%)	-53.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-454%)	-21.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-117.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-881%)	—	-182.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1316%)	46.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+210%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	—	—	—	—	0.47x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-34%)	5.56x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+694%)	0.89x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+27%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—
Interest Coverage (x)	-19.92x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.76x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-42.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-441.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-83.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.32x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	-39.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-2.99M	$-9.17M	$-17.95M	$-5.09M	$-24.57M	$-22.12M	$2.77M	$-7.49M	$-1.02M	—
Debt / EBITDA (x)	—	—	—	—	—	-0.44x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.81x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$5.24	$24.21	$3.81K	$3.47K	$2.34K	—	—	—	—	—
Basic EPS, GAAP (USD)	$-4.85	$-88.13	$-24.57K	$-16.59K	$-9.38K	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.00	$-54.23	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.14	$18.96	$7.58K	—	—	$6.66K	$3.80K	—	—	—
Tangible Book Value per Share (USD)	$3.73	$13.76	$4.90K	—	—	$5.02K	$3.80K	—	—	—
Basic Weighted Avg Shares (shares)	5.45M	1.27M	9,467	8,017	7,673	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$22.44M	$2.15M	$40.09M	$121.41M	$250.57M	$37.85M	$1.89M	$18.50M	$-9.51M	—
LT Debt (USD)	—	—	—	—	—	$16.33M	$20.08M	$9.03M	$0.00	—
Total Equity (USD)	$44.42M	$35.38M	$96.16M	$249.40M	$337.12M	$35.08M	$3.61M	$10.14M	$-50.23M	$-27.26M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$28.51M	$30.78M	$36.12M	$27.80M	$17.98M	$8.50M	$10.13M	$12.00M	$9.51M	—
Depreciation Expense (USD)	$9.53M	$14.02M	$13.71M	$9.62M	$3.35M	$1.48M	$1.13M	$1.32M	$1.50M	—
Net Income, GAAP (USD)	$-26.39M	$-112.02M	$-232.49M	$-132.60M	$-72.44M	$-41.11M	$-29.82M	$-18.50M	$-23.37M	—
Operating Cash Flow (USD)	$-16.34M	$-68.92M	$-125.18M	$-124.82M	$-71.93M	$-38.31M	$-29.53M	$-19.94M	$-20.82M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters

Bionano Genomics, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BNGO with peers